Skip to main content
Top
Published in: Cancer Causes & Control 10/2008

01-12-2008 | Review Article

Physical activity as a negative modulator of estrogen-induced breast cancer

Author: Yvonne M. Coyle

Published in: Cancer Causes & Control | Issue 10/2008

Login to get access

Abstract

Physical activity is a protective factor for breast cancer. Exposure to estrogen is an important determinant of breast cancer risk and exercise reduces estrogen levels, with the level of evidence being stronger for post-menopausal women. Possible mechanisms for estrogen induced breast cancer include increased breast epithelial cell proliferation, the metabolism of estrogen to genotoxic metabolites, such as DNA-adducts, and the silencing of tumor suppressor genes (TSGs) that have been implicated in breast carcinogenesis by inducing gene promoter hypermethylation, which is potentially reversible. Animal studies suggest that physical activity decreases breast tumor growth by promoting changes in cellular proliferation and apoptosis. Human studies provide some support for exercise producing favorable changes in estrogen metabolism that may lead to reduced breast epithelial cell proliferation. No studies have been performed to determine whether exercise decreases the accumulation of estrogen metabolite DNA-adducts in breast tissue. However, research supports the hypothesis that physical activity reduces promoter hypermethylation of TSGs implicated in breast carcinogenesis by lowering circulating estrogen levels. Thus, further research is necessary to clarify the mechanisms that relate to physical activity as a negative modulator of breast cancer risk to develop meaningful guidelines for the use of physical activity in breast cancer prevention.
Literature
1.
go back to reference World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC
2.
go back to reference International Agency for Research on Cancer (2002) IARC handbooks of cancer prevention, vol 6. Weight control and physical activity. IARC Press, Lyon International Agency for Research on Cancer (2002) IARC handbooks of cancer prevention, vol 6. Weight control and physical activity. IARC Press, Lyon
3.
go back to reference Adams-Campbell LL, Rosenberg L, Rao RS, Palmer JR (2001) Strenuous physical activity and breast cancer risk in African-American women. J Natl Med Assoc 93:267–275PubMed Adams-Campbell LL, Rosenberg L, Rao RS, Palmer JR (2001) Strenuous physical activity and breast cancer risk in African-American women. J Natl Med Assoc 93:267–275PubMed
4.
go back to reference John EM, Horn-Ross PL, Koo J (2003) Lifetime physical activity and breast cancer risk in a multiethnic population, The San Francisco Bay Area Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 12:1143–1152PubMed John EM, Horn-Ross PL, Koo J (2003) Lifetime physical activity and breast cancer risk in a multiethnic population, The San Francisco Bay Area Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 12:1143–1152PubMed
6.
go back to reference Ueji M, Ueno E, Osei-Hyiaman D, Takahashi H, Kano K (1997) Physical activity and the risk of breast cancer, a case–control study of Japanese women. J Epidemiol 8:115–122 Ueji M, Ueno E, Osei-Hyiaman D, Takahashi H, Kano K (1997) Physical activity and the risk of breast cancer, a case–control study of Japanese women. J Epidemiol 8:115–122
12.
go back to reference Cohen LA, Choi K, Wang CX (1988) Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitrosomethylurea-induced mammary tumorigenesis in rats. Cancer Res 48:4276–4283PubMed Cohen LA, Choi K, Wang CX (1988) Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitrosomethylurea-induced mammary tumorigenesis in rats. Cancer Res 48:4276–4283PubMed
13.
go back to reference Cohen LA, Choi K, Backlund JY, Harris R, Wang CX (1991) Modulation of N-nitrosomethylurea induced mammary tumorigenesis by dietary fat and voluntary exercise. In Vivo 5:333–344PubMed Cohen LA, Choi K, Backlund JY, Harris R, Wang CX (1991) Modulation of N-nitrosomethylurea induced mammary tumorigenesis by dietary fat and voluntary exercise. In Vivo 5:333–344PubMed
14.
go back to reference Cohen LA, Kendall ME, Meschter C, Epstein MA, Reinhardt J, Zang E (1993) Inhibition of rat mammary tumorigenesis by voluntary exercise. In Vivo 7:151–158PubMed Cohen LA, Kendall ME, Meschter C, Epstein MA, Reinhardt J, Zang E (1993) Inhibition of rat mammary tumorigenesis by voluntary exercise. In Vivo 7:151–158PubMed
15.
go back to reference Thompson HJ (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54:1960s–1963sPubMed Thompson HJ (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54:1960s–1963sPubMed
16.
go back to reference Thompson HJ, Westerlind KC, Snedden J, Briggs S, Meenakshi S (1995) Exercise intensity dependent inhibition of 1-methyl-1-nitrosourea induced mammary carcinogenesis in female F-344 rats. Carcinogenesis 16(8):1783–1786PubMedCrossRef Thompson HJ, Westerlind KC, Snedden J, Briggs S, Meenakshi S (1995) Exercise intensity dependent inhibition of 1-methyl-1-nitrosourea induced mammary carcinogenesis in female F-344 rats. Carcinogenesis 16(8):1783–1786PubMedCrossRef
17.
go back to reference Whittal KS, Parkhouse WS (1996) Exercise during adolescence and its effects on mammary gland development, proliferation, and nitrosomethylurea (NMU) induced tumorigenesis in rats. Breast Cancer Res Treat 37:21–27. doi:10.1007/BF01806628 PubMedCrossRef Whittal KS, Parkhouse WS (1996) Exercise during adolescence and its effects on mammary gland development, proliferation, and nitrosomethylurea (NMU) induced tumorigenesis in rats. Breast Cancer Res Treat 37:21–27. doi:10.​1007/​BF01806628 PubMedCrossRef
20.
go back to reference Pike MC, Henderson BE, Casagrande JT (1981) The epidemiology of breast cancer as it relates to menarche, pregnancy and menopause. In: Pike MC, Siiter PK, Welsh C (eds) Hormones and breast cancer. Cold Spring Harbor Laboratory, New York, pp 3–13 Pike MC, Henderson BE, Casagrande JT (1981) The epidemiology of breast cancer as it relates to menarche, pregnancy and menopause. In: Pike MC, Siiter PK, Welsh C (eds) Hormones and breast cancer. Cold Spring Harbor Laboratory, New York, pp 3–13
22.
go back to reference Coyle YM, Xie X-J, Lewis CM, Bu D, Milchgrub S, Euhus D (2006) Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in non-malignant breast tissue. Cancer Epidemiol Biomarkers Prev 16:192–196. doi:10.1158/1055-9965.EPI-06-0700 CrossRef Coyle YM, Xie X-J, Lewis CM, Bu D, Milchgrub S, Euhus D (2006) Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in non-malignant breast tissue. Cancer Epidemiol Biomarkers Prev 16:192–196. doi:10.​1158/​1055-9965.​EPI-06-0700 CrossRef
23.
24.
go back to reference Lonning PE, Helle SI, Johannessen DC, Ekse E, Adlercreutz H (1996) Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer. Breast Cancer Res Treat 29:335–341. doi:10.1007/BF01806162 CrossRef Lonning PE, Helle SI, Johannessen DC, Ekse E, Adlercreutz H (1996) Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer. Breast Cancer Res Treat 29:335–341. doi:10.​1007/​BF01806162 CrossRef
25.
go back to reference Combined Hormone Trialists’ Group the European Organization for Research, Treatment of Cancer (2001) Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist along in premenopausal advanced breast cancer, a meta-analysis of four randomized trials. J Clin Oncol 19:343–353 Combined Hormone Trialists’ Group the European Organization for Research, Treatment of Cancer (2001) Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist along in premenopausal advanced breast cancer, a meta-analysis of four randomized trials. J Clin Oncol 19:343–353
26.
go back to reference Hankinson SE (2005/2006) Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 24:3–15 Hankinson SE (2005/2006) Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 24:3–15
27.
go back to reference The Endogenous Hormones Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women, reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616 The Endogenous Hormones Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women, reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616
28.
go back to reference Siiteri PK (1987) Adipose tissue as a source of hormones. Am J Clin Nutr 45:277–282PubMed Siiteri PK (1987) Adipose tissue as a source of hormones. Am J Clin Nutr 45:277–282PubMed
30.
go back to reference Wysowski DK, Comstock GW, Helsing KJ, Lau HL (1987) Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemol 125(5):791–799 Wysowski DK, Comstock GW, Helsing KJ, Lau HL (1987) Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemol 125(5):791–799
31.
go back to reference Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW (1994) A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 18:79–85PubMed Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW (1994) A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 18:79–85PubMed
32.
go back to reference Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo PG (1994) Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 140(6):518–525PubMed Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo PG (1994) Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 140(6):518–525PubMed
33.
go back to reference Thomas HV, Key TJ, Allen DS et al (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 75(7):1075–1079PubMed Thomas HV, Key TJ, Allen DS et al (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 75(7):1075–1079PubMed
34.
go back to reference Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE (2000) A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 9:575–579PubMed Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE (2000) A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 9:575–579PubMed
35.
go back to reference Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 97(10):755–765PubMedCrossRef Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 97(10):755–765PubMedCrossRef
36.
go back to reference Eliassen AH, Missmer SA, Tworoger SS et al (2005) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406–1415 Eliassen AH, Missmer SA, Tworoger SS et al (2005) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406–1415
37.
go back to reference Russell J, Mitchell D, Musey PI, Collins DC (1984) The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstet Gynecol 63:452–456PubMed Russell J, Mitchell D, Musey PI, Collins DC (1984) The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstet Gynecol 63:452–456PubMed
38.
go back to reference Broocks A, Pirke KM, Schweiger U, Tuschl RJ, Laessle RG, Strowitzki T et al (1990) Cyclic ovarian function in recreational athletes. J Appl Physiol 68(5):2083–2086PubMed Broocks A, Pirke KM, Schweiger U, Tuschl RJ, Laessle RG, Strowitzki T et al (1990) Cyclic ovarian function in recreational athletes. J Appl Physiol 68(5):2083–2086PubMed
40.
go back to reference Bullen BA, Skrinar GS, Beitins IZ, von Mering G, Turnbull BA, McArthur JW (1985) Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med 312:1349–1353PubMed Bullen BA, Skrinar GS, Beitins IZ, von Mering G, Turnbull BA, McArthur JW (1985) Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med 312:1349–1353PubMed
41.
go back to reference Beitins IZ, McArthur JW, Turnbull BA, Skrinar GS, Bullen BA (1991) Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone. J Clin Endocrinol Metab 72:1350–1358PubMed Beitins IZ, McArthur JW, Turnbull BA, Skrinar GS, Bullen BA (1991) Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone. J Clin Endocrinol Metab 72:1350–1358PubMed
44.
go back to reference Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson SE (2007) Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women. Cancer Causes Control 18:743–752. doi:10.1007/s10552-007-9017-5 PubMedCrossRef Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson SE (2007) Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women. Cancer Causes Control 18:743–752. doi:10.​1007/​s10552-007-9017-5 PubMedCrossRef
45.
go back to reference Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ (1988) Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocrinol Metab 66:927–933PubMed Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ (1988) Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocrinol Metab 66:927–933PubMed
46.
go back to reference Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120–1131PubMed Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120–1131PubMed
48.
go back to reference Chan M-F, Dowsett M, Folkerd E et al (2007) Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-Norfolk population study. Cancer Epidemiol Biomarkers Prev 16:900–905. doi:10.1158/1055-9965.EPI-06-0745 PubMedCrossRef Chan M-F, Dowsett M, Folkerd E et al (2007) Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-Norfolk population study. Cancer Epidemiol Biomarkers Prev 16:900–905. doi:10.​1158/​1055-9965.​EPI-06-0745 PubMedCrossRef
55.
go back to reference Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1993) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144 Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1993) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144
58.
go back to reference Aiello EJ, Buist DSM, White E (2006) Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States). Cancer Causes Control 17:1227–1235PubMedCrossRef Aiello EJ, Buist DSM, White E (2006) Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States). Cancer Causes Control 17:1227–1235PubMedCrossRef
61.
go back to reference Atkinson C, Warren R, Bingham A, Day NE (1999) Mammographic patterns as a predictive marker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 8:863–866PubMed Atkinson C, Warren R, Bingham A, Day NE (1999) Mammographic patterns as a predictive marker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 8:863–866PubMed
62.
go back to reference Ursin G, Astrahan MA, Salane M et al (1998) The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 7:43–47PubMed Ursin G, Astrahan MA, Salane M et al (1998) The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 7:43–47PubMed
64.
65.
go back to reference Tamini RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178–1187. doi:10.1093/jnci/djm062 CrossRef Tamini RM, Byrne C, Colditz GA, Hankinson SE (2007) Endogenous hormone levels, mammographic density and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 99:1178–1187. doi:10.​1093/​jnci/​djm062 CrossRef
66.
go back to reference Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876–882 Boyd NF, Stone J, Martin LJ et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87:876–882
67.
go back to reference Greendale GA, Palla SL, Ursin G (2005) The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the postmenopausal estrogen/progestin interventions mammographic density study. Am J Epidemiol 162(9):826–834. doi:10.1093/aje/kwi286 PubMedCrossRef Greendale GA, Palla SL, Ursin G (2005) The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the postmenopausal estrogen/progestin interventions mammographic density study. Am J Epidemiol 162(9):826–834. doi:10.​1093/​aje/​kwi286 PubMedCrossRef
68.
go back to reference Gram IT, Funkhouser E, Tabar L (1999) Moderate physical activity in relation to mammographic patterns. Cancer Epidemiol Biomarkers Prev 8:117–122PubMed Gram IT, Funkhouser E, Tabar L (1999) Moderate physical activity in relation to mammographic patterns. Cancer Epidemiol Biomarkers Prev 8:117–122PubMed
69.
go back to reference Vachon CM, Kuni CC, Anderson K, Anderson E, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic factors for breast cancer (United States). Cancer Causes Control 11:653–662. doi:10.1023/A:1008926607428 PubMedCrossRef Vachon CM, Kuni CC, Anderson K, Anderson E, Sellers TA (2000) Association of mammographically defined percent breast density with epidemiologic factors for breast cancer (United States). Cancer Causes Control 11:653–662. doi:10.​1023/​A:​1008926607428 PubMedCrossRef
70.
go back to reference Suijkerbuijk KPM, Van Duijnhoven FJB, Van Gils CH et al (2006) Physical activity in relation to mammographic density on the Dutch prospect-European prospective investigation into cancer and nutrition cohort. Cancer Epidemiol Biomarkers Prev 15:456–460. doi:10.1158/1055-9965.EPI-05-0569 PubMedCrossRef Suijkerbuijk KPM, Van Duijnhoven FJB, Van Gils CH et al (2006) Physical activity in relation to mammographic density on the Dutch prospect-European prospective investigation into cancer and nutrition cohort. Cancer Epidemiol Biomarkers Prev 15:456–460. doi:10.​1158/​1055-9965.​EPI-05-0569 PubMedCrossRef
71.
go back to reference Oestriecher N, Capra A, Bromberger J et al (2008) Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc 40(3):451–466 Oestriecher N, Capra A, Bromberger J et al (2008) Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc 40(3):451–466
72.
75.
go back to reference Meilahn EN, De Stavola B, Allen DS et al (1998) Do urinary oestrogen metabolites predict breast cancer? Br J Cancer 78:1250–1255PubMed Meilahn EN, De Stavola B, Allen DS et al (1998) Do urinary oestrogen metabolites predict breast cancer? Br J Cancer 78:1250–1255PubMed
77.
78.
go back to reference De Cree C, Ball P, Seiditz B, Van Kranenburg G, Geuten P, Keizer HA (1998) Responsiveness of plasma 2- and 4-hydroxycatecholestrogens to training and to graduate submaximal and maximal exercise in an untrained woman. Interuniversity project on reproductive endocrinology in women and exercise. Int J Sports Med 19:20–25. doi:10.1055/s-2007-971874 PubMedCrossRef De Cree C, Ball P, Seiditz B, Van Kranenburg G, Geuten P, Keizer HA (1998) Responsiveness of plasma 2- and 4-hydroxycatecholestrogens to training and to graduate submaximal and maximal exercise in an untrained woman. Interuniversity project on reproductive endocrinology in women and exercise. Int J Sports Med 19:20–25. doi:10.​1055/​s-2007-971874 PubMedCrossRef
80.
go back to reference Frisch RE, Snow RC, Johnson LA, Gerard B, Barbieri R, Rosen B (1993) Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls. J Clin Endocrinol Metab 77:471–477. doi:10.1210/jc.77.2.471 PubMedCrossRef Frisch RE, Snow RC, Johnson LA, Gerard B, Barbieri R, Rosen B (1993) Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls. J Clin Endocrinol Metab 77:471–477. doi:10.​1210/​jc.​77.​2.​471 PubMedCrossRef
81.
go back to reference Snow RC, Barbieri RL, Frisch RE (1989) Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab 69:369–376PubMedCrossRef Snow RC, Barbieri RL, Frisch RE (1989) Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab 69:369–376PubMedCrossRef
82.
go back to reference Bentz AT, Schneider CM, Westerlind KC (2005) The relationship between physical activity and 2-hydroxyestrone, 16α-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States). Cancer Causes Control 16:455–461. doi:10.1007/s10552-004-6256-6 PubMedCrossRef Bentz AT, Schneider CM, Westerlind KC (2005) The relationship between physical activity and 2-hydroxyestrone, 16α-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States). Cancer Causes Control 16:455–461. doi:10.​1007/​s10552-004-6256-6 PubMedCrossRef
84.
go back to reference Campbell KL, Westerlind KC, Harber VJ, Bell GJ, Mackey JR, Courneya KS (2007) Effects of aerobic exercise training and estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 16:731–739. doi:10.1158/1055-9965.EPI-06-0784 PubMedCrossRef Campbell KL, Westerlind KC, Harber VJ, Bell GJ, Mackey JR, Courneya KS (2007) Effects of aerobic exercise training and estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 16:731–739. doi:10.​1158/​1055-9965.​EPI-06-0784 PubMedCrossRef
85.
go back to reference Atkinson C, Lampe JW, Tworoger SS et al (2004) Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:868–874PubMed Atkinson C, Lampe JW, Tworoger SS et al (2004) Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:868–874PubMed
86.
go back to reference De Cree C, Ball P, Seidlitz B, Van Kranenburg G, Geurten P, Keizer HA (1997) Responses of catecholestrogen metabolism to acute graded exercise in normal menstruating women before and after training. J Clin Endocrinol Metab 82:3342–3348. doi:10.1210/jc.82.10.3342 PubMedCrossRef De Cree C, Ball P, Seidlitz B, Van Kranenburg G, Geurten P, Keizer HA (1997) Responses of catecholestrogen metabolism to acute graded exercise in normal menstruating women before and after training. J Clin Endocrinol Metab 82:3342–3348. doi:10.​1210/​jc.​82.​10.​3342 PubMedCrossRef
87.
go back to reference De Cree C, Van Kranenburg G, Geurten P, Fujimori Y, Keizer HA (1997) 4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer. Fertil Steril 67:505–516. doi:10.1016/S0015-0282(97)80078-7 PubMedCrossRef De Cree C, Van Kranenburg G, Geurten P, Fujimori Y, Keizer HA (1997) 4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer. Fertil Steril 67:505–516. doi:10.​1016/​S0015-0282(97)80078-7 PubMedCrossRef
89.
go back to reference Greim H, Csanady G, Filser G et al (1995) Biomarkers as tools in human risk assessment. Clin Chem 41:1804–1808PubMed Greim H, Csanady G, Filser G et al (1995) Biomarkers as tools in human risk assessment. Clin Chem 41:1804–1808PubMed
93.
go back to reference Fernandez SV, Wu YZ, Russo IH, Plass CP, Russo J (2006) The role of DNA methylation in estrogen-induced transformation of human breast epithelial cells. Proc Am Assoc Cancer Res 47:1590 Fernandez SV, Wu YZ, Russo IH, Plass CP, Russo J (2006) The role of DNA methylation in estrogen-induced transformation of human breast epithelial cells. Proc Am Assoc Cancer Res 47:1590
94.
go back to reference Klein CB, Leszczynska J (2005) Estrogen-induced DNA methylation of E-cadherin & p16 in non-tumor breast cells. Proc Am Assoc Cancer Res 46:2744 Klein CB, Leszczynska J (2005) Estrogen-induced DNA methylation of E-cadherin & p16 in non-tumor breast cells. Proc Am Assoc Cancer Res 46:2744
95.
go back to reference Lewis CM, Cler LR, Bu DW et al (2005) Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 11:166–172PubMed Lewis CM, Cler LR, Bu DW et al (2005) Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 11:166–172PubMed
97.
go back to reference Thompson HJ (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54(Suppl):1960s–1963sPubMed Thompson HJ (1994) Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54(Suppl):1960s–1963sPubMed
98.
Metadata
Title
Physical activity as a negative modulator of estrogen-induced breast cancer
Author
Yvonne M. Coyle
Publication date
01-12-2008
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 10/2008
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9186-x

Other articles of this Issue 10/2008

Cancer Causes & Control 10/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine